Related Experiment Video
Updated: Oct 23, 2025

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method
Published on: July 4, 2021
SELP Asp603Asn and severe thrombosis in COVID-19 males
Chiara Fallerini1,2, Sergio Daga1,2, Elisa Benetti2
1Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Viale Bracci, 2, 53100, Siena, Italy.
Insights
COVID-19 severity and mortality are linked to blood clots. A specific gene variant in males, particularly those over 50, increases this risk, suggesting targeted P-selectin therapies.
Area of Science:
- Genetics and Genomics
- Infectious Diseases
- Cardiovascular Medicine
Background:
- Thromboembolism is a major contributor to COVID-19 severity and mortality.
- The underlying causes of COVID-19-associated thromboembolism remain unclear.
- This study investigated genetic factors influencing COVID-19 severity in relation to thrombosis.
Discussion:
- The homozygosity of the SELP gene variant rs6127 (Asp603Asn) is associated with increased COVID-19 severity in males.
- This association is more pronounced in males over 50, potentially due to testosterone's downregulation of SELP.
- Combined homozygosity for SELP rs6127 and specific androgen receptor genotypes (poly Q ≥ 23) further elevates D-dimer levels, indicating heightened thrombotic risk.
Key Insights:
- Identified a significant association between the SELP rs6127 variant and COVID-19 severity in males.
- Demonstrated an age-dependent effect in males over 50, linked to hormonal regulation.
- Revealed an interaction between SELP genotype and androgen receptor variants impacting thrombotic markers.
Outlook:
- Suggests P-selectin targeted therapies, such as antibodies, as potential adjuvant treatments for high-risk male COVID-19 patients.
- Highlights the need for personalized medicine approaches based on genetic profiling.
- Further research into the role of sex hormones and genetic variants in COVID-19 pathogenesis is warranted.
Abstract:
Thromboembolism is a frequent cause of severity and mortality in COVID-19. However, the etiology of this phenomenon is not well understood. A cohort of 1186 subjects, from the GEN-COVID consortium, infected by SARS-CoV-2 with different severity was stratified by sex and adjusted by age. Then, common coding variants from whole exome sequencing were mined by LASSO logistic regression. The homozygosity of the cell adhesion molecule P-selectin gene (SELP) rs6127 (c.1807G > A; p.Asp603Asn) which has been already associated with thrombotic risk is found to be associated with severity in the male subcohort of 513 subjects (odds ratio = 2.27, 95% Confidence Interval 1.54-3.36). As the SELP gene is downregulated by testosterone, the odd ratio is increased in males older than 50 (OR 2.42, 95% CI 1.53-3.82). Asn/Asn homozygotes have increased D-dimers values especially when associated with poly Q ≥ 23 in the androgen receptor (OR 3.26, 95% CI 1.41-7.52). These results provide a rationale for the repurposing of antibodies against P-selectin as adjuvant therapy in rs6127 male homozygotes especially if older than 50 or with an impaired androgen receptor.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Single Nucleotide Polymorphisms-SNPs
Anticoagulant Drugs: Low-Molecular-Weight Heparins

